ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
REIN THERAPEUTICS INC
1.23
-0.0150
-1.21%
成交量：
1.57萬
成交額：
1.92萬
市值：
3,220.08萬
市盈率：
-0.49
高：
1.26
開：
1.20
低：
1.19
收：
1.24
52周最高：
2.40
52周最低：
1.02
股本：
2,628.64萬
流通股本：
2,235.40萬
量比：
0.20
換手率：
0.07%
股息：
- -
股息率：
- -
每股收益(TTM):
-2.5002
每股收益(LYR):
-3.5054
淨資產收益率：
-83.28%
總資產收益率：
-18.81%
市淨率：
27.17
市盈率(LYR):
-0.35
資料載入中...
總覽
公司
新聞資訊
公告
Rein Therapeutics, Inc.盤中異動 早盤快速上漲7.89%
市场透视
·
03/02
Rein Therapeutics, Inc.盤中異動 急速上漲6.98%報1.38美元
市场透视
·
02/04
Rein Therapeutics, Inc.盤中異動 快速下挫7.44%報1.12美元
市场透视
·
01/20
BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton
路透中文
·
01/20
BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton
路透中文
·
01/20
BUZZ-治療肺部疤痕疾病的藥物獲得歐盟孤兒藥地位，Rein Therapeutics 股價上漲
路透中文
·
01/20
Rein Therapeutics：決定終止與Yorkville於7月29日簽署的備用股權購買協議
美股速递
·
2025/12/12
REIN THERAPEUTICS INC：決定終止與Ya Ii Pn簽訂的7月29日預付協議 - SEC備案
美股速递
·
2025/12/12
REIN THERAPEUTICS INC：因選擇終止Ppa和Sepa協議未產生罰款或費用
美股速递
·
2025/12/12
Rein Therapeutics發布新科學出版物，表明Lti-03可能減少肺部疤痕並保護肺修復所需細胞
美股速递
·
2025/11/06
REIN THERAPEUTICS INC獲得FDA批准恢復在美國進行Lti-03的第二階段試驗
美股速递
·
2025/11/03
Rein Therapeutics獲得歐洲監管部門批准，啓動Lti-03治療特發性肺纖維化的二期臨床試驗
美股速递
·
2025/10/09
REIN THERAPEUTICS INC - FDA建議公司提交完整回應函處理修訂研究報告及相關説明 - SEC文件
美股速递
·
2025/09/22
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RNTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RNTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","market":"US","secType":"STK","nameCN":"REIN THERAPEUTICS INC","latestPrice":1.225,"timestamp":1774287905855,"preClose":1.24,"halted":0,"volume":15656,"delay":0,"changeRate":-0.012096774193548309,"floatShares":22354000,"shares":26286382,"eps":-2.500246,"marketStatus":"交易中","change":-0.015,"latestTime":"03-23 13:59:26 EDT","open":1.2,"high":1.26,"low":1.185,"amount":19188.5775688,"amplitude":0.060484,"askPrice":1.23,"askSize":102,"bidPrice":1.21,"bidSize":121,"shortable":0,"etf":0,"ttmEps":-2.500246,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"listingDate":1498708800000,"exchange":"NASDAQ","adjPreClose":1.24,"preHourTrading":{"tag":"盘前","latestPrice":1.21,"preClose":1.24,"latestTime":"08:07 EDT","volume":501,"amount":606.21,"timestamp":1774267669421,"change":-0.03,"changeRate":-0.024194,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.24,"preClose":1.24,"latestTime":"16:10 EDT","volume":29,"amount":35.96,"timestamp":1774037405147,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.201885},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","floatShares":22354000,"roa":"-18.81%","roe":"-83.28%","lyrEps":-3.505399,"volumeRatio":0.201885,"shares":26286382,"dividePrice":0,"high":1.26,"amplitude":0.060484,"preClose":1.24,"low":1.185,"week52Low":1.02,"pbRate":"27.17","week52High":2.4,"institutionHeld":0,"latestPrice":1.225,"committee":0.085202,"eps":-2.500246,"divideRate":0,"volume":15656,"delay":0,"ttmEps":-2.500246,"open":1.2,"prevYearClose":1.16,"prevWeekClose":1.24,"prevMonthClose":1.14,"prevQuarterClose":1.16,"fiveDayClose":1.36,"twentyDayClose":1.17,"sixtyDayClose":1.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"RNTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.24,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2025-08-14","symbol":"RNTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-05-15","symbol":"RNTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-04-07","symbol":"RNTX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-14","symbol":"RNTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1769054400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNTX","date":"2026-03-20","current":-0.491952,"percent":0.47973,"low":-2.000549,"twenty":-0.79198,"median":-0.575859,"eighty":-0.504312,"high":-0.401342,"avg":-0.750983,"sd":0.401209,"marketCap":34172296},"quantilePoints":[{"date":"2025-01-17","current":-1.459659,"twenty":-1.48337,"median":-1.467068,"eighty":-1.447804,"marketCap":42681903},{"date":"2025-01-24","current":-1.630077,"twenty":-1.576729,"median":-1.478183,"eighty":-1.446322,"marketCap":47665070},{"date":"2025-01-31","current":-1.467069,"twenty":-1.741219,"median":-1.496707,"eighty":-1.462623,"marketCap":42898563},{"date":"2025-02-07","current":-1.704171,"twenty":-1.704171,"median":-1.526344,"eighty":-1.459659,"marketCap":49831664},{"date":"2025-02-14","current":-1.741218,"twenty":-1.704171,"median":-1.578211,"eighty":-1.462623,"marketCap":50914961},{"date":"2025-02-21","current":-1.98573,"twenty":-1.794566,"median":-1.630077,"eighty":-1.468551,"marketCap":58064721},{"date":"2025-02-28","current":-1.533754,"twenty":-1.79753,"median":-1.630077,"eighty":-1.47596,"marketCap":44848497},{"date":"2025-03-07","current":-1.467069,"twenty":-1.753073,"median":-1.607848,"eighty":-1.468551,"marketCap":42898563},{"date":"2025-03-14","current":-1.496707,"twenty":-1.741218,"median":-1.552277,"eighty":-1.467069,"marketCap":43765200},{"date":"2025-03-21","current":-1.430022,"twenty":-1.733809,"median":-1.518935,"eighty":-1.461141,"marketCap":41815266},{"date":"2025-03-28","current":-1.311471,"twenty":-1.704171,"median":-1.507821,"eighty":-1.431504,"marketCap":38348715},{"date":"2025-04-04","current":-1.259605,"twenty":-1.704171,"median":-1.496707,"eighty":-1.416685,"marketCap":36832099},{"date":"2025-04-11","current":-0.545587,"twenty":-1.696762,"median":-1.481888,"eighty":-1.32629,"marketCap":34308123},{"date":"2025-04-17","current":-0.577063,"twenty":-1.667124,"median":-1.474478,"eighty":-1.296652,"marketCap":36287438},{"date":"2025-04-25","current":-0.640015,"twenty":-1.630077,"median":-1.467069,"eighty":-1.259605,"marketCap":40246068},{"date":"2025-05-02","current":-0.573565,"twenty":-1.630077,"median":-1.459659,"eighty":-0.64701,"marketCap":36067514},{"date":"2025-05-09","current":-0.601544,"twenty":-1.630077,"median":-1.437431,"eighty":-0.622528,"marketCap":37826905},{"date":"2025-05-16","current":-0.825375,"twenty":-1.622667,"median":-1.430022,"eighty":-0.622528,"marketCap":51902033},{"date":"2025-05-23","current":-0.696336,"twenty":-1.607848,"median":-1.415203,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-05-30","current":-0.696336,"twenty":-1.584138,"median":-1.407793,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-06-06","current":-0.705061,"twenty":-1.560428,"median":-1.311471,"eighty":-0.635119,"marketCap":43199785},{"date":"2025-06-13","current":-0.712292,"twenty":-1.550055,"median":-1.296652,"eighty":-0.639316,"marketCap":43642859},{"date":"2025-06-20","current":-0.592974,"twenty":-1.539682,"median":-1.259605,"eighty":-0.638616,"marketCap":36332127},{"date":"2025-06-27","current":-0.524276,"twenty":-1.524863,"median":-1.24849,"eighty":-0.622528,"marketCap":32122917},{"date":"2025-07-03","current":-0.54597,"twenty":-1.518935,"median":-0.809312,"eighty":-0.609134,"marketCap":33452141},{"date":"2025-07-11","current":-0.535123,"twenty":-1.515971,"median":-0.771713,"eighty":-0.598047,"marketCap":32787529},{"date":"2025-07-18","current":-0.506198,"twenty":-1.508562,"median":-0.726755,"eighty":-0.578462,"marketCap":31015230},{"date":"2025-07-25","current":-0.513429,"twenty":-1.504116,"median":-0.717873,"eighty":-0.562281,"marketCap":31458305},{"date":"2025-08-01","current":-0.421229,"twenty":-1.501152,"median":-0.708677,"eighty":-0.556817,"marketCap":25809102},{"date":"2025-08-08","current":-0.417509,"twenty":-1.496707,"median":-0.703515,"eighty":-0.543648,"marketCap":25581194},{"date":"2025-08-15","current":-0.434435,"twenty":-1.490779,"median":-0.698131,"eighty":-0.532953,"marketCap":26618269},{"date":"2025-08-22","current":-0.445213,"twenty":-1.481888,"median":-0.696336,"eighty":-0.524276,"marketCap":26334772},{"date":"2025-08-29","current":-0.445213,"twenty":-1.478924,"median":-0.689114,"eighty":-0.516321,"marketCap":26334772},{"date":"2025-09-05","current":-0.537801,"twenty":-1.474478,"median":-0.673872,"eighty":-0.514875,"marketCap":31811472},{"date":"2025-09-12","current":-0.425513,"twenty":-1.472996,"median":-0.650825,"eighty":-0.513429,"marketCap":25169516},{"date":"2025-09-19","current":-0.453092,"twenty":-1.467069,"median":-0.643512,"eighty":-0.506198,"marketCap":26800874},{"date":"2025-09-26","current":-0.470822,"twenty":-1.467069,"median":-0.629523,"eighty":-0.496939,"marketCap":27849604},{"date":"2025-10-03","current":-0.457032,"twenty":-1.465587,"median":-0.622528,"eighty":-0.470507,"marketCap":27033925},{"date":"2025-10-10","current":-0.539771,"twenty":-1.459659,"median":-0.615534,"eighty":-0.469167,"marketCap":31927997},{"date":"2025-10-17","current":-0.504312,"twenty":-1.455213,"median":-0.601544,"eighty":-0.470507,"marketCap":29830538},{"date":"2025-10-24","current":-0.496432,"twenty":-1.437431,"median":-0.598047,"eighty":-0.472004,"marketCap":29364436},{"date":"2025-10-31","current":-0.61069,"twenty":-1.435949,"median":-0.596299,"eighty":-0.477169,"marketCap":36122917},{"date":"2025-11-07","current":-0.61463,"twenty":-1.430022,"median":-0.598047,"eighty":-0.479267,"marketCap":36355968},{"date":"2025-11-14","current":-0.531891,"twenty":-1.430022,"median":-0.598047,"eighty":-0.480672,"marketCap":31461895},{"date":"2025-11-21","current":-0.616035,"twenty":-1.42854,"median":-0.59455,"eighty":-0.480672,"marketCap":36275207},{"date":"2025-11-28","current":-0.700851,"twenty":-1.422612,"median":-0.598047,"eighty":-0.480672,"marketCap":41269619},{"date":"2025-12-05","current":-0.620499,"twenty":-1.415203,"median":-0.603206,"eighty":-0.482843,"marketCap":36538070},{"date":"2025-12-12","current":-0.687459,"twenty":-1.415203,"median":-0.607107,"eighty":-0.492492,"marketCap":40481028},{"date":"2025-12-19","current":-0.575859,"twenty":-1.407793,"median":-0.606928,"eighty":-0.496432,"marketCap":33909432},{"date":"2025-12-26","current":-0.589251,"twenty":-1.390011,"median":-0.606928,"eighty":-0.496432,"marketCap":34698024},{"date":"2026-01-02","current":-0.517826,"twenty":-1.341109,"median":-0.603755,"eighty":-0.496432,"marketCap":30492203},{"date":"2026-01-09","current":-0.54461,"twenty":-1.311471,"median":-0.601544,"eighty":-0.497777,"marketCap":32069386},{"date":"2026-01-16","current":-0.517826,"twenty":-1.30258,"median":-0.596299,"eighty":-0.498849,"marketCap":30492203},{"date":"2026-01-23","current":-0.598179,"twenty":-1.296652,"median":-0.593762,"eighty":-0.499215,"marketCap":35223751},{"date":"2026-01-30","current":-0.638355,"twenty":-1.293688,"median":-0.598047,"eighty":-0.499741,"marketCap":37589526},{"date":"2026-02-06","current":-0.508898,"twenty":-1.277387,"median":-0.593762,"eighty":-0.500131,"marketCap":29966475},{"date":"2026-02-13","current":-0.52229,"twenty":-1.259605,"median":-0.589251,"eighty":-0.501948,"marketCap":30755066},{"date":"2026-02-20","current":-0.49997,"twenty":-1.259605,"median":-0.58056,"eighty":-0.49997,"marketCap":29440747},{"date":"2026-02-27","current":-0.535682,"twenty":-1.255159,"median":-0.578693,"eighty":-0.50005,"marketCap":31543658},{"date":"2026-03-06","current":-0.531218,"twenty":-1.154976,"median":-0.575859,"eighty":-0.50116,"marketCap":31280794},{"date":"2026-03-13","current":-0.571395,"twenty":-0.81895,"median":-0.571395,"eighty":-0.504312,"marketCap":33646568},{"date":"2026-03-20","current":-0.580323,"twenty":-0.79198,"median":-0.575859,"eighty":-0.504312,"marketCap":34172296}],"updateTime":1774288766031},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616209355","title":"Rein Therapeutics, Inc.盤中異動 早盤快速上漲7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616209355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616209355?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 22:30","pubTimestamp":1772461833,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时30分，Rein Therapeutics, Inc.股票出现异动，股价大幅上涨7.89%。截至发稿，该股报1.23美元/股，成交量3327股，换手率0.01%，振幅0.00%。Rein Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Rallybio Corporation、Xeris制药涨幅较大，Ensysce Biosciences, Inc.、Rallybio Corporation、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为65.76%、22.90%、14.46%，振幅较大的相关个股有Polaryx Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Rapport Therapeutics, Inc.，振幅分别为6.56%、5.21%、5.09%。Rein Therapeutics, Inc.公司简介：Rein Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223033a4428b56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223033a4428b56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNTX","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2608804008","title":"Rein Therapeutics, Inc.盤中異動 急速上漲6.98%報1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608804008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608804008?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 00:23","pubTimestamp":1770135837,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日00时23分，Rein Therapeutics, Inc.股票出现异动，股价快速上涨6.98%。Rein Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Liminatus Pharma, Inc.涨幅较大，Cdt Equity Inc.、Pmgc Holdings Inc.、Liminatus Pharma, Inc.较为活跃，换手率分别为650.41%、596.30%、55.11%，振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为70.33%、68.89%、47.28%。Rein Therapeutics, Inc.公司简介：Rein Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204002357a6cf3b0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204002357a6cf3b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNTX","BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2604114004","title":"Rein Therapeutics, Inc.盤中異動 快速下挫7.44%報1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604114004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604114004?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 22:30","pubTimestamp":1768919426,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时30分，Rein Therapeutics, Inc.股票出现波动，股价大幅跳水7.44%。截至发稿，该股报1.12美元/股，成交量12.4943万股，换手率0.48%，振幅3.31%。Rein Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Corvus Pharmaceuticals, Inc.、Rapt Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Jaguar Health, Inc.、Dermata Therapeutics, Inc.、Rapt Therapeutics, Inc.较为活跃，换手率分别为47.56%、45.96%、37.68%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、Galecto, Inc.、Impact Biomedical, Inc.，振幅分别为6.78%、4.00%、3.54%。Rein Therapeutics, Inc.公司简介：Rein Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223027a44180b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223027a44180b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4539","RNTX"],"gpt_icon":0},{"id":"2604191361","title":"BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton","url":"https://stock-news.laohu8.com/highlight/detail?id=2604191361","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604191361?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 22:12","pubTimestamp":1768918352,"startTime":"0","endTime":"0","summary":"nL6N3YE109 ** BioXcel Therapeutics Inc BTAI.O:BUZZ - 寻求美国食品和药物管理局批准家用激动疗法；股价下跌 nL4N3YL11K ** Netflix Inc NFLX.O:BUZZ - 上涨；提交对华纳兄弟的全现金修正报价 nL4N3YL0TJ ** StandardAero Inc SARO.N:BUZZ - 在纳入标准普尔中型股之前上涨 nL6N3YL0M1 ** Novavax Inc NVAX.O:BUZZ - 与辉瑞签署疫苗开发许可协议后上涨 nL4N3YL13N ** Invivyd Inc IVVD.O:BUZZ - 将推出针对长期COVID、疫苗相关疾病的抗体试验；股价下跌 nL4N3YL14D ** ServiceNow Inc NOW.N:BUZZ - 因报道软件公司与 OpenAI 签订协议而上涨 nL4N3YL16C ** Fastenal Co FAST.O:BUZZ - 因第四季度营收不及预期而下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4S3YL1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0690374615.EUR","RNTX","SARO","INTC","NVAX","USAW.SI","PFE","LU2087625088.SGD","FAST","RAPT","ALHC","NEM","BK4612","IBRX","LU1691799644.USD","IVVD","BTAI","NOW","FCEL","BK4579","CRML","CDW","DHI","TOST","NTAP","CEG","WBD","LU0683600562.USD","NFLX","LU1548497426.USD","LU1814569148.SGD","LU0006306889.USD","IE00BKVL7J92.USD","MMM","NRG","PM","LU0690374961.EUR","ONDS","LU1267930573.SGD","BK4613","LU0061474960.USD","IE00BFXG0V08.USD","LU0170899867.USD","BK4575","AMZN","LU0965509283.SGD","VST","IE00B19Z9505.USD","TLN"],"gpt_icon":0},{"id":"2604119139","title":"BUZZ--美國股票走勢-Netflix、ServiceNow、D.R. Horton","url":"https://stock-news.laohu8.com/highlight/detail?id=2604119139","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604119139?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 22:12","pubTimestamp":1768918352,"startTime":"0","endTime":"0","summary":"nL6N3YE109 ** BioXcel Therapeutics Inc BTAI.O:BUZZ - 寻求美国食品和药物管理局批准家用激动疗法；股价下跌 nL4N3YL11K ** Netflix Inc NFLX.O:BUZZ - 上涨；提交对华纳兄弟的全现金修正报价 nL4N3YL0TJ ** StandardAero Inc SARO.N:BUZZ - 在纳入标准普尔中型股之前上涨 nL6N3YL0M1 ** Novavax Inc NVAX.O:BUZZ - 与辉瑞签署疫苗开发许可协议后上涨 nL4N3YL13N ** Invivyd Inc IVVD.O:BUZZ - 将推出针对长期COVID、疫苗相关疾病的抗体试验；股价下跌 nL4N3YL14D ** ServiceNow Inc NOW.N:BUZZ - 因报导软件公司与 OpenAI 签订协议而上涨 nL4N3YL16C ** Fastenal Co FAST.O:BUZZ - 因第四季度营收不及预期而下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4T3YL1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRG","LU1861558580.USD","SG9999001077.SGD","WBD","CDW","ALHC","LU1923623000.USD","NOW","LU1951200564.SGD","CEG","PFE","LU1951198990.SGD","DHI","IE00BLSP4239.USD","RNTX","NTAP","IE00BWXC8680.SGD","NFLX","MMM","LU2125909247.SGD","FAST","LU0345780521.USD","RAPT","TLN","TOST","IVVD","IE00BMPRXN33.USD","SARO","FCEL","BK4088","NVAX","BTAI","SG9999001176.USD","LU0345770993.USD","PM","LU1868837300.USD","USAW.SI","LU0672654240.SGD","LU1069344957.HKD","LU0345769631.USD","LU1244550577.SGD","LU0477156953.USD","NEM"],"gpt_icon":1},{"id":"2604311524","title":"BUZZ-治療肺部疤痕疾病的藥物獲得歐盟孤兒藥地位，Rein Therapeutics 股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2604311524","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604311524?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 21:30","pubTimestamp":1768915847,"startTime":"0","endTime":"0","summary":"BUZZ-治疗肺部疤痕疾病的药物获得欧盟孤儿药地位，Rein Therapeutics 股价上涨1月20日 - ** 药物开发商Rein Therapeutics RNTX.O股价盘前上涨2.5%至1.24美元 ** 该公司称 ，欧洲监管机构授予其用于治疗特发性肺纤维化的实验性疗法LTI-03孤儿药地位，IPF是一种致命的肺部疤痕疾病。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4T3YL1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"1148175807","title":"Rein Therapeutics：決定終止與Yorkville於7月29日簽署的備用股權購買協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1148175807","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148175807?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 06:31","pubTimestamp":1765492294,"startTime":"0","endTime":"0","summary":"Rein Therapeutics：决定终止与Yorkville于7月29日签署的备用股权购买协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1171260931","title":"REIN THERAPEUTICS INC：決定終止與Ya Ii Pn簽訂的7月29日預付協議 - SEC備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1171260931","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171260931?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 06:28","pubTimestamp":1765492092,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC：决定终止与Ya Ii Pn签订的7月29日预付协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1137663344","title":"REIN THERAPEUTICS INC：因選擇終止Ppa和Sepa協議未產生罰款或費用","url":"https://stock-news.laohu8.com/highlight/detail?id=1137663344","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137663344?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 06:28","pubTimestamp":1765492089,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC：因选择终止Ppa和Sepa协议未产生罚款或费用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1157029139","title":"Rein Therapeutics發布新科學出版物，表明Lti-03可能減少肺部疤痕並保護肺修復所需細胞","url":"https://stock-news.laohu8.com/highlight/detail?id=1157029139","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157029139?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 20:33","pubTimestamp":1762432429,"startTime":"0","endTime":"0","summary":"Rein Therapeutics发布新科学出版物，表明Lti-03可能减少肺部疤痕并保护肺修复所需细胞。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1185602073","title":"REIN THERAPEUTICS INC獲得FDA批准恢復在美國進行Lti-03的第二階段試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1185602073","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185602073?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 20:31","pubTimestamp":1762173071,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC获得FDA批准，恢复其在特发性肺纤维化（Idiopathic Pulmonary Fibrosis）领域的Lti-03的第二阶段临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"1122656434","title":"Rein Therapeutics獲得歐洲監管部門批准，啓動Lti-03治療特發性肺纖維化的二期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1122656434","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122656434?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 19:42","pubTimestamp":1760010157,"startTime":"0","endTime":"0","summary":"Rein Therapeutics获得欧洲监管部门批准，启动Lti-03治疗特发性肺纤维化的二期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1141656991","title":"REIN THERAPEUTICS INC - FDA建議公司提交完整回應函處理修訂研究報告及相關説明 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1141656991","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141656991?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 20:06","pubTimestamp":1758542777,"startTime":"0","endTime":"0","summary":"据向SEC提交的文件显示，FDA建议REIN THERAPEUTICS INC提交完整回应函，以处理修订后的研究报告和相关证明材料。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}